Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059121 · ClinicalTrials.gov registry record
The Cleveland Cardiometabolic Cohort
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 56
- Enrollment target
NCT03059121: Completed study, sponsored by University Hospitals Cleveland Medical Center.
NCT03059121 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03059121 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.
Primary Outcome
Assessed using DEXA (dual energy x-ray absorptiometry) scans which will be quantifying total body fat
Interventions
- DIAGNOSTIC_TEST Dual-energy X-ray absorptiometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2016-09 |
| Est. Completion | 2025-05-19 |
What the finished NCT03059121 record still lists
NCT03059121 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dual-energy X-ray absorptiometry is the first listed.
NCT03059121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03059121 about?
NCT03059121 is a clinical study titled "The Cleveland Cardiometabolic Cohort". In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.
What is the current status of trial NCT03059121?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2016-09. Estimated completion is 2025-05-19.
What interventions are being tested in trial NCT03059121?
The interventions under investigation include: Dual-energy X-ray absorptiometry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03059121?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia